With official figures showing pregabalin related deaths to 111 and gabapentin related deaths to 59, the Home Office launched on 13th November three options for the reclassification of these two drugs. The options for its reclassification includes schedule 3, this...
The full impact of Brexit may not be known for years to come, but it is clear the implications it has for healthcare in the UK and Europe. A survey of EU doctors by BMA found 42% of EU doctors admitted to considering leaving the UK as a result of the Brexit vote. The...
Cosmetic procedures allowed to be performed on patients, without the patient knowing if the person performing it was qualified to do so. Nuffield Council on Bioethics reported on Cosmetic Procedures: Ethical Issues stated, “there is nothing to stop completely...
Controversial from the start, prescription charges were introduced in 1952, abolished in 1965 and then reintroduced in 1968 with a system of exemptions that persists in modified form today. The charge itself has risen from 20p in 1979 to the current price of £8.60 per...
The US Food and Drug Administration gets drugs to the market faster than other major regulators but it is still too slow. Can approvals be achieved quicker without affecting patient safety? Companies can take years to submit their applications. Ivabradine took 51...
“An excellent course with almost 1/1 training. Interactive, knowledgeable trainer. Excellent venue.”Dr. Parry – Course Rating 10/10
GDP & RP Training
“The course was very informative and delivered by Brian in a positive way with lots of examples, to help understand the various topics.”Kalpesh Patel – Course Rating 9/10
GDP & RP Training
Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training
“Very Informative. Great handouts to take away. Thanks”Megan – Course Rating 10/10
We appointed PCL to assist us with our new CQC compliance registration. From start to finish, they acted with professionalism and expertise; taking what at first seemed to be a tedious and daunting process and making it clear and easy to understand. Even after our successful registration, the consultant remained on hand to answer any outstanding questions and to ensure that we felt adequately prepared for a potential visit from the CQC. Having had such a positive experience, we have no hesitatio… Read more
Pharmacy developing patient services
The course covered all areas I was expecting and very well presented considering how it was delivered during the current situation.Clare Durbin12/05/2020
Cogent Gold Standard GDP Online Training
“Very informative training day.”“Highly recommended”
“A very small group (2 of us attending) but this was excellent! Very interactive course, very informative. Gained a lot of information to take away. Thank you very much.”Jane Lytwynchuk – Course Rating 10/10
GDP & RP Training
I found Pharmacy Consulting Ltd’s (PCL) input into the planning and installation of our ARX V Max extremely beneficial to the project.The senior consultant from PCL met with me, the ARX project manager, and members of my shop fitting team, and we discussed the new pharmacy planned layout from PCL’s automation experience. This was useful as having previously worked with robots, and also being a pharmacist he could provide valuable advice on where the machine outputs would be best positi… Read more